Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Revaclear 500, Revaclear 400, Revaclear 300

K-Number: K213639 · 2022-01-24

Decision Date2022-01-24
Product CodeKDI
Advisory CommitteeGU
DecisionSubstantially Equivalent

Device Summary

Revaclear 500, Revaclear 400, Revaclear 300 is a medical device manufactured by Baxter Healthcare Corporation. It received FDA 510(k) clearance on 2022-01-24 under approval number K213639. The device is classified under product code KDI. It was reviewed by the GU advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Revaclear 500, Revaclear 400, Revaclear 300?

Revaclear 500, Revaclear 400, Revaclear 300 is a medical device that received FDA 510(k) clearance on 2022-01-24. It is manufactured by Baxter Healthcare Corporation. The 510(k) number is K213639.

When was Revaclear 500, Revaclear 400, Revaclear 300 approved by the FDA?

Revaclear 500, Revaclear 400, Revaclear 300 received FDA 510(k) clearance on 2022-01-24, under approval number K213639.

What company makes Revaclear 500, Revaclear 400, Revaclear 300?

Revaclear 500, Revaclear 400, Revaclear 300 is manufactured by Baxter Healthcare Corporation.

What is the FDA product code for Revaclear 500, Revaclear 400, Revaclear 300?

The FDA product code for Revaclear 500, Revaclear 400, Revaclear 300 is KDI.

Other Devices by Baxter Healthcare Corporation

View all 48 devices →

Related Devices (Code: KDI)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.